ATARA BIOTHERAPEUTICS, INC. Proceeds from Common Stock Issued
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Proceeds from Common Stock Issued of $7.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2026-06-30 was $4.83M.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2026-03-31 was $2.95M.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2025-12-31 was -$25.00K.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $1.50M.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2025 was $1.47M, a 84.26% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2024 was $9.35M, a 337.64% increase from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2023 was $2.14M, a 90.24% decline from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2022 was $21.89M, a 77.82% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 4 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.78M 10-Q · filed 2026-08-12 | $7.75M derived: sum of 3 quarters · filed 2026-08-12 | $9.25M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $2.95M 10-Q · filed 2026-05-12 | $2.93M derived: sum of 2 quarters · filed 2026-05-12 | $4.42M derived: sum of 3 quarters · filed 2026-05-12 | $4.42M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.47M derived: sum of 2 quarters · filed 2026-03-16 | $1.47M derived: sum of 3 quarters · filed 2026-08-12 | $1.47M 10-K · filed 2026-03-16 | ||
| 2025-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.50M derived: sum of 2 quarters · filed 2026-08-12 | $1.50M 10-Q · filed 2025-11-12 | $1.50M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | -$26.00K derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | -$26.00K derived: sum of 3 quarters · filed 2026-03-16 | $9.35M 10-K · filed 2026-03-16 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$26.00K derived: sum of 2 quarters · filed 2025-11-12 | $9.35M 10-Q · filed 2025-11-12 | $10.89M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $9.35M 10-Q · filed 2025-08-11 | $10.89M derived: sum of 3 quarters · filed 2025-08-11 | $10.89M derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $9.37M 10-Q · filed 2025-05-15 | $10.92M derived: sum of 2 quarters · filed 2025-05-15 | $10.92M derived: sum of 3 quarters · filed 2025-05-15 | $10.87M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.55M derived: sum of 2 quarters · filed 2025-03-07 | $1.50M derived: sum of 3 quarters · filed 2025-03-07 | $2.14M 10-K · filed 2025-03-07 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$50.00K derived: sum of 2 quarters · filed 2024-11-12 | $590.00K 10-Q · filed 2024-11-12 | $1.97M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $590.00K 10-Q · filed 2024-08-12 | $1.97M derived: sum of 3 quarters · filed 2024-08-12 | $1.97M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $640.00K 10-Q · filed 2024-05-09 | $2.02M derived: sum of 2 quarters · filed 2024-05-09 | $2.02M derived: sum of 3 quarters · filed 2024-05-09 | $1.99M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.38M derived: sum of 2 quarters · filed 2024-03-28 | $1.35M derived: sum of 3 quarters · filed 2024-03-28 | $21.89M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$23.00K derived: sum of 2 quarters · filed 2023-11-01 | $20.52M 10-Q · filed 2023-11-01 | $70.47M derived: sum of 4 quarters · filed 2023-11-01 | ||
| 2022-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $20.52M 10-Q · filed 2023-08-08 | $70.47M derived: sum of 3 quarters · filed 2023-08-08 | $116.83M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $20.54M 10-Q · filed 2023-05-08 | $70.50M derived: sum of 2 quarters · filed 2023-05-08 | $116.85M derived: sum of 3 quarters · filed 2023-05-08 | $116.78M derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $49.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $96.31M derived: sum of 2 quarters · filed 2023-02-08 | $96.24M derived: sum of 3 quarters · filed 2023-02-08 | $98.70M 10-K · filed 2023-02-08 | ||
| 2021-09-30 | $46.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $46.28M derived: sum of 2 quarters · filed 2022-11-08 | $48.74M 10-Q · filed 2022-11-08 | $59.88M derived: sum of 4 quarters · filed 2023-02-08 | ||
| 2021-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.38M 10-Q · filed 2022-08-08 | $13.53M derived: sum of 3 quarters · filed 2023-02-08 | $47.40M derived: sum of 4 quarters · filed 2023-02-08 | ||
| 2021-03-31 | $2.46M 10-Q · filed 2022-05-05 | $13.60M derived: sum of 2 quarters · filed 2023-02-08 | $47.47M derived: sum of 3 quarters · filed 2023-02-08 | $47.37M derived: sum of 4 quarters · filed 2023-02-08 | ||
| 2020-12-31 | $11.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $45.02M derived: sum of 2 quarters · filed 2023-02-08 | $44.91M derived: sum of 3 quarters · filed 2023-02-08 | $69.19M 10-K · filed 2023-02-08 | ||
| 2020-09-30 | $33.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $33.77M derived: sum of 2 quarters · filed 2021-11-04 | $58.05M 10-Q · filed 2021-11-04 | $93.14M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $24.17M 10-Q · filed 2021-08-09 | $59.27M derived: sum of 3 quarters · filed 2022-02-28 | $64.27M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $24.28M 10-Q · filed 2021-05-04 | $59.38M derived: sum of 2 quarters · filed 2022-02-28 | $64.38M derived: sum of 3 quarters · filed 2022-02-28 | $72.01M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $35.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $40.10M derived: sum of 2 quarters · filed 2022-02-28 | $47.73M derived: sum of 3 quarters · filed 2022-02-28 | $47.73M 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $12.63M derived: sum of 2 quarters · filed 2020-11-09 | $12.63M 10-Q · filed 2020-11-09 | $12.63M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $7.63M 10-Q · filed 2020-08-05 | $7.63M derived: sum of 3 quarters · filed 2021-03-01 | $7.63M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | -$245.70M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | -$245.70M derived: sum of 3 quarters · filed 2021-03-01 | $47.59M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$245.70M derived: sum of 2 quarters · filed 2019-11-07 | $47.59M 10-Q · filed 2019-11-07 | $47.54M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | -$245.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $47.59M 10-Q · filed 2019-08-08 | $47.54M derived: sum of 3 quarters · filed 2020-02-27 | $57.42M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $293.29M 10-Q · filed 2018-05-08 | $293.24M derived: sum of 2 quarters · filed 2020-02-27 | $303.12M derived: sum of 3 quarters · filed 2020-02-27 | $312.45M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $9.83M derived: sum of 2 quarters · filed 2020-02-27 | $19.16M derived: sum of 3 quarters · filed 2020-02-27 | $19.16M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $9.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $19.21M derived: sum of 2 quarters · filed 2018-11-06 | $19.21M 10-Q · filed 2018-11-06 | $19.21M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $9.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $9.33M 10-Q · filed 2018-08-01 | $9.33M derived: sum of 3 quarters · filed 2019-02-26 | $9.33M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-07 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $193.99M derived: sum of 2 quarters · filed 2017-03-09 | $193.95M derived: sum of 3 quarters · filed 2017-03-09 | $263.43M 10-K · filed 2017-03-09 | ||
| 2015-09-30 | $193.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $193.95M derived: sum of 2 quarters · filed 2016-11-04 | $263.43M 10-Q · filed 2016-11-04 | |||
| 2015-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $69.44M 10-Q · filed 2016-08-08 | $69.49M 10-Q · filed 2015-08-07 | |||
| 2015-03-31 | $69.49M 10-Q · filed 2016-05-06 | |||||
| 2014-12-31 | $56.45M 10-K · filed 2017-03-09 | |||||
| 2012-12-31 | $91.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |